Vantage logo

Akero’s imperfect Harmony

An apparent hit in Nash has more than doubled the group’s market cap. But are the data all they seem?

Vantage logo

The Wegovy wait continues

Novo Nordisk delays the full US launch of its obesity drug again, as Lilly breathes down its neck.